Down's Syndrome—Transient Abnormal Myelopoiesis and Acute Leukaemia

References

• Fong C., Brodeur G. M. Down's syndrome and leukemia: epidemiology, genetics, cytogenetics and mechanisms of leukemogenesis. Cancer Genetics and Cytogenetics 1987; 28: 55–76
   PubMed Web of Science ®Google Scholar
• Rosner F., Lee S. L. Down's syndrome and acute leukemia: myeloblastic or lymphoblastic? Report of forty-three cases and review of the literature. American Journal of Medicine 1972; 53: 203–218
   PubMed Web of Science ®Google Scholar
• Fabia J., Drolette M. Malformations and leukemia in children with Down's syndrome. Pediatrics 1970; 45: 60–70
   PubMed Web of Science ®Google Scholar
• Lewis D. S., Thompson M, Hudson E., Liberman M. M., Samson D. Down's syndrome and acute megakaryoblastic leukaemia. Case report and review of the literature. Acta Haematologica 1983; 70: 236–242
   PubMed Web of Science ®Google Scholar
• Zipursky A., Peeters M., Poon A. Megakaryoblastic leukemia and Down's syndrome: a review. Pediatric Hematology and Oncology 1987; 4: 211–230
   PubMed Web of Science ®Google Scholar
• Robinson L. L., Nesbit M. E., Sather H. N., Level C., Shahidi N., Kennedy A., Hammond D. Down syndrome and acute leukemia in children: A 10-year retrospective survey from Childrens Cancer Study Group. Journal of Pediatrics 1984; 105: 235–242
   PubMed Web of Science ®Google Scholar
• Nakagawa T., Nishida H., Arai T., Yamada T., Fukuda M., Sakamota S. Hyperviscosity syndrome with transient abnormal myelopoiesis in Down syndrome. Journal of Pediatrics 1988; 112: 58–61
   PubMed Web of Science ®Google Scholar
• Bessho F., Hayashi Y., Hayashi Y., Ohga K. Ultrastructural studies of peripheral blood of neonates with Down's syndrome and transient abnormal myelopoiesis. American Journal of Clinical Pathology 1988; 88: 627–633
   Google Scholar
• Suda J., Eguchi M., Akiyama Y., Iwama Y., Furukawa T., Sata Y., Miura Y., Suda T., Saito M. Differentiation of blast cells from a Down's syndrome patient with transient myeloproliferative disorder. Blood 1987; 69: 508–512
   PubMed Web of Science ®Google Scholar
• Wong K. Y., Jones M. M., Srivastava A. K., Gruppo R. A. Transient myeloproliferative disorder and acute nonlymphoblastic leukemia in Down syndrome. Journal of Pediatrics 1988; 112: 18–22
   PubMed Web of Science ®Google Scholar
• Conen P. E., Erkman B. Combined mongolism and leukemia. American Journal of Diseases of Children 1964; 112: 429–443
   Google Scholar
• Miller J. McC., Sherrill J. G., Hathaway W. E. Thrombocythemia in the myeloproliferative disorder of Down's syndrome. Pediatrics 1967; 40: 847–850
   PubMed Web of Science ®Google Scholar
• Koide R., Takahashi H., Tsunematsu Y., Sasaki M., Sugita K., Nakazawa S., Enomoto Y., Watanabe Y., Kaneko Y. Megakaryocyte proliferative disorder in neonates with Down's syndrome. The Keio Journal of Medicine 1987; 36: 57–61
   PubMedGoogle Scholar
• Lazarus K. H., Heerema N. A., Palmer C. G., Baehner R. L. The myeloproliferative reaction in a child with Down syndrome: cytological and chromosomal evidence for a transient leukemia. American Journal of Hematology 1981; 1: 417–423
   Web of Science ®Google Scholar
• Denegri J. F., Rogers P. C. J., Chan K. W., Sadoway J., Thomas J. W. In vitro cell growth in neonates with Down's syndrome and transient myeloproliferative disorder. Blood 1981; 58: 675–677
   PubMed Web of Science ®Google Scholar
• Mendelow B., Krawitz S., Cohn R., Bernstein R. Leukemic pattern of in vitro growth in a patient with Down syndrome and transient myeloproliferative disorder. American Journal of Hematology 1984; 16: 293–296
   PubMed Web of Science ®Google Scholar
• Coulombel L., Derycke M., Villeval J. L., Leonard C., Breton-Gorius J., Vial M., Bourgeois P., Tchernia G. Characterization of the blast cell population in two neonates with Down's syndrome and transient myeloproliferative disorder. British Journal of Haematology 1987; 66: 69–76
   PubMed Web of Science ®Google Scholar
• Barak Y., Mogilner B. M., Karov Y., Nir E., Schesinger M., Levin S. Transient acute leukaemia in a newborn with Down's syndrome. Prediction of its reversibility by bone marrow cultures. Acta Paediatrica Scandinavica 1982; 71: 699–701
   PubMed Web of Science ®Google Scholar
• de Alarcon P. A., Patil S., Goldberg J., Allen J. B., Shaw S. Infants with Down's syndrome: use of cytogenetic studies and in vitro colony assays for granulocyte progenitor to distinguish acute nonlymphocytic leukemia from a transient myeloproliferative disorder. Cancer 1987; 60: 987–993
   PubMed Web of Science ®Google Scholar
• Nagao T., Lampkin B. C., Hug G. A neonate with Down's syndrome and transient abnormal myelopoiesis. Serial blood and bone marrow studies. Blood 1970; 36: 443–447
   PubMed Web of Science ®Google Scholar
• Miller M., Congriff J. M. Hematological abnormalities in newborn infants with Down syndrome. American Journal of Medical Genetics 1983; 16: 173–177
   PubMed Web of Science ®Google Scholar
• Weinberger M. M., Ollinick A. Congenital marrow dysfunction in Down's syndrome. Journal of Pediatrics 1970; 77: 273–279
   PubMed Web of Science ®Google Scholar
• Shibata A., Koike T., Aoki S., Maruyama S., Ishizuka T., Otsuka T. Characterization of proliferating cells in transient abnormal myelopoiesis: ultrastructural and immunocytochemical study. The Keio Journal of Medicine 1987; 36: 62–66
   PubMedGoogle Scholar
• Paolucci G., Rosito P. Neonatal myeloproliferative disorders in Down's syndrome and congenital leukemias. Haematologica 1987; 72: 121–125, (Suppl)
   PubMedGoogle Scholar
• Hayashi Y., Eguchi M., Sugita K., Nakazawa S., Sato T., Kojima S., Bessho F., Konishi S., Inaba T., Hanada R., Yamamota K. Cytogenetic findings and clinical features in acute leukemia and transient myeloproliferative disorder in Down's syndrome. Blood 1988; 72: 15–23
   PubMed Web of Science ®Google Scholar
• Cant-Rajnoldi A., Cattoretti G., Caccamo M. L., Biasini A., Bagnato L., Schero R., Polli N. Leukaemoid reaction with megakaryocytic features in newborns with Down's syndrome. European Journal of Haematology 1988; 40: 403–409
   PubMed Web of Science ®Google Scholar
• Morgan R., Hecht F., Cleary M. L., Sklar J., Link M. P. Leukemia with Down's syndrome: translocation between 1 and 19 in acute myelomonocytic leukemia following transient congenital myeloproliferative syndrome. Blood 1985; 66: 1466–1468
   PubMed Web of Science ®Google Scholar
• Honda F., Punnett H. H., Charney E., Miller G., Thiede H. A. Serial cytogenetic and hematologic studies on a mongol with trisomy-21 and acute congenital leukemia. Journal of Pediatrics 1964; 65: 880–887
   PubMed Web of Science ®Google Scholar
• Gardais J., Larget-Piet L., Leroux J-P, Vidal J-L. Leucoblastose n<142>o-natale transitoire puis leucose aigu<145> chez un trisomique 21. Semaine des Hopitaux de Paris 1969; 45: 3136–3142
   Google Scholar
• Lin H-P., Menaka H., Lim K-H, Yong H-S. Congenital leukemoid reaction followed by fatal leukemia. American Journal of Diseases of Childhood 1980; 134: 939–941
   PubMedGoogle Scholar
• Chu J-K. Acute leukemia in a patient with Down's syndrome and transient congenital leukemia. American Journal of Diseases of Children 1982; 136: 367
   PubMedGoogle Scholar
• Nito T., Terashima K., Matsuda M., Imai Y., Yokoyama S., Hayashi T. Transient abnormal myelopoiesis followed by acute megakaryoblastic leukemia with extramedullary tumors: an autopsied case of Down's syndrome. Acta Pathologica Japonica 1983; 33: 1027–1039
   PubMedGoogle Scholar
• Yokoyama S., Nito T., Irimada K., Yoshimura Y., Hayashi T. Acute megakaryoblastic leukemia preceded by refractory anaemia with an excess of blast cells: leukemic transformation in an infant with Down syndrome recovering from transient abnormal myelopoiesis. Acta Haematologica Japonica 1984; 47: 62–70
   PubMed Web of Science ®Google Scholar
• Wang N., Leung J., Warrier R. P., Schorin M., Kirkpatrick D., Nowak M. J., Strand R. Nonrandom chromosomal aberrations and clonal chromosomal evolution in acute leukemia associated with Down's syndrome. Cancer Genetics and Cytogenetics 1987; 28: 155–162
   PubMed Web of Science ®Google Scholar
• Group Franais de Cytogntique Hmatologique. Cytogenetic findings in leukemic cells of 56 patients with constitutional chromosomal abnormalities. Cancer Genetics and Cytogenetics 1988; 35: 243–252
   PubMed Web of Science ®Google Scholar
• Van Eys J., Flexner J. M. Transient spontaneous remission in a case of untreated congenital leukemia. American Journal of Diseases of Children 1969; 118: 507–514
   PubMedGoogle Scholar
• Brodeur G. M., Dahl G. V., Williams D. L., Tipton R. E., Kalwinsky D. K. Transient leukemoid reaction and trisomy 21 mosaicism in a phenotypically normal newborn. Blood 1980; 55: 691–693
   PubMed Web of Science ®Google Scholar
• Heaton D. C., Fitzgerald P. H., Fraser G. J., Abbott G. D. Transient leukemoid proliferation of the cytogenetically unbalanced +21 cell line of a constitutional mosaic baby. Blood 1981; 57: 883–887
   PubMed Web of Science ®Google Scholar
• Seibel N. L., Sommer A., Miser J. Transient neonatal leukemoid reactions in mosiac trisomy 21. Journal of Pediatrics 1984; 104: 251–254
   PubMed Web of Science ®Google Scholar
• Weinberg A. G., Schiller G., Windmiller J. Neonatal leukemoid reaction. An isolated manifestation of mosaic trisomy 21. American Journal of Diseases of Children 1982; 136: 310–311
   PubMedGoogle Scholar
• Cairney E. A. L., McKenna R., Arthur D. C., Nesbit M. E., William G. Acute megakaryoblastic leukaemia in children. British Journal of Haematology 1986; 63: 541–554
   PubMed Web of Science ®Google Scholar
• Van Den Berghe H., Vermaelen K., Broeckaert-Van Orshoven A., Delbeke M-J., Benoit Y., Orye E., Van Eygen M., Logghe N. Pentasomy 21 characterizing spontaneously regressing congenital acute leukemia. Cancer Genetics and Cytogenetics 1983; 9: 19–24
   PubMed Web of Science ®Google Scholar
• Rogers P. C. J., Thomas J. W., Kalousek D. K., Baker M. A., Denegri J. F. Neonate with Down's syndrome and transient congenital leukemia: in vitro studies. American Journal of Pediatric Hematology and Oncology 1983; 5: 59–64
   PubMedGoogle Scholar
• Ross J. D., Atkins L. Chromosomal anomaly in a mongol with leukaemia. Lancet 1962; ii: 612–613
   Google Scholar
• Alimena G., Billstrm R., Casalone R., Gallo E., Mitelman F., Pasquali F. Cytogenetic patterns in leukemic cells of patients with constitutional chromosomal anomalies. Cancer Genetics and Cytogenetics 1985; 16: 207–218
   PubMed Web of Science ®Google Scholar
• Engel R. R., Hammond D., Fitzman D. V., Pearson H., Krivit W. Transient congenital leukemia in seven infants with mongolism. Journal of Pediatrics 1964; 65: 303–305
   PubMed Web of Science ®Google Scholar
• Weill J., Lai J. L., Zandecki M., Blanckaert D., Pont C. I. R<142>action leuc<142>mo<149>de transitoire avec <142>volution clonal regressive chez un nouveau-n<142> mongolien. Archives Francaise de Pediatrie 1983; 40: 785–788
   PubMedGoogle Scholar
• La J. L., Zandecki M., Weill J., Cosson A., Ponte C., Deminatti M. Leucoblastose et dysm<142>gacaryocytopo<149><143>se transitoires avec clone 46 XX + 21, t(5;7) chez un nouveau-n<142> trisomique 21. Nouvelle Revue Francaise Hematologie 1983; 25: 363–367
   Google Scholar
• Adams R. H., Lemons R. S., Thangavelu M., Le Beau M. M., Christensen R. D. Interstitial deletion of chromosome 5, del(5q), in a newborn with Down syndrome and an unusual hematologic disorder. American Journal of Hematology 1989; 31: 273–279
   PubMed Web of Science ®Google Scholar
• Villeval J. L., Cramer F., Lemoine A., Henri A., Bettaieb A., Bernaudin F., Beuzard Y., Berger R., Flandrin G., Breton-Gorius J., Vainchenker W. Phenotype of early erythroblastic leukemias. Blood 1986; 68: 1167–1174
   PubMed Web of Science ®Google Scholar
• Chaptal J., Jean R., Izam P., Bonnet H., Emberger J-M., Navarro M., Rieu D. Troubles h<142>matologiques des jeunes mongoliens. Pediatrie 1970; 25: 433–442
   PubMedGoogle Scholar
• Debiec-Rychter M., Kaluzewski B., Zajaczkowska D., Pokuszynska K. Mosaicism 48, XX, +8, +21/47, XX, +21 in Down syndrome and rapid progression from preleukaemia to acute leukaemia. Lancet 1982; ii: 448–449
   Google Scholar
• Bevan D., Rose M., Greaves M. Leukaemia of platelet precursors: diverse features in four cases. British Journal of Haematology 1982; 51: 147–164
   PubMed Web of Science ®Google Scholar
• Peeters M., Poon A. Down syndrome and leukemia: unusual clinical aspects and unexpected methotrexate toxity. European Journal of Pediatrics 1987; 146: 416–422
   PubMed Web of Science ®Google Scholar
• Kaneko Y., Rowley J. D., Variakojis D., Chilcote R. R., Moohr J. W., Patel D. Chromosome abnormalities in Down's syndrome patients with acute leukemia. Blood 1981; 58: 459–466
   PubMed Web of Science ®Google Scholar
• Smith A. G., Willoughby M. L. N. Preleukaemia in Down's syndrome. Blood 1982; 59: 870
   PubMedGoogle Scholar
• Broomhead A. F., Kwan Y. L., Zell N. A., Lam-Po-Tang P. R. L., Hughes D. O'G. Acute leukemia characterized by trisomy 8 in Down's syndrome. Pathology 1988; 17: 111–114
   Google Scholar
• Goh K-o., Lee H., Miller G. Down's syndrome and leukemia: mechanism of additional chromosomal abnormalities. American Journal of Mental Deficiency 1978; 6: 542–548
   Google Scholar
• Misawa S., Testa J. R., Strauss L. C., Leavitt R. D., Civin C. I. Acquired chromosome rearrangements including fine interstitial deletions in a patient with Down's syndrome and monoblastic leukemia. Pediatrics 1984; 74: 1029–1033
   PubMed Web of Science ®Google Scholar